Barinthus Biotherapeutics Income Statement (2020-2025) | BRNS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.70M0.51M3.25M0.35M0.21M0.04M0.02M-0.00M15.02M17.06M6.17M6.46M0.47M0.33M14.97M0.32M0.00M
Operating items
Research & Development 4.24M3.88M3.70M2.57M4.61M4.51M4.37M6.88M10.70M9.72M9.74M12.19M9.81M13.54M15.14M6.37M11.12M11.66M11.14M8.31M8.29M7.95M5.39M
Selling, General & Administrative 1.11M0.97M0.98M7.42M1.78M12.37M1.18M9.79M3.66M12.14M13.13M0.96M13.62M5.99M7.20M13.42M3.06M12.64M15.38M5.17M
Other Operating Expenses -5.89M-10.81M19.36M12.21M4.67M
Operating Expenses 5.35M4.85M4.68M9.99M6.39M16.88M5.55M16.67M14.36M3.83M-1.07M31.55M21.95M26.67M16.11M19.99M17.12M18.86M24.56M23.57M20.93M23.34M15.22M
Operating Income -4.65M-4.34M-1.43M-9.63M-6.17M-16.84M-5.54M-16.67M0.65M13.23M7.24M-25.09M-21.48M-26.34M-16.11M-19.99M-16.91M-18.29M-9.38M-23.39M-20.60M-23.32M-15.07M
EBIT -4.65M-4.34M-1.43M-9.63M-6.17M-16.84M-5.54M-16.67M0.65M13.23M7.24M-25.09M-21.48M-26.34M-16.11M-19.99M-16.91M-18.29M-9.38M-23.39M-20.60M-23.32M-15.07M
Non-operating items
Interest & Investment Income 0.00M0.08M0.67M1.02M1.33M1.59M0.52M0.20M0.57M0.78M0.64M0.63M0.64M0.56M0.52M0.47M
Other Non Operating Income 0.98M1.06M-13.79M-0.00M13.79M0.05M0.52M0.31M-0.00M0.77M0.02M0.03M0.09M0.07M0.32M-0.28M
Non Operating Income 0.70M0.68M1.63M-0.80M-9.28M0.87M0.96M1.53M1.06M1.54M0.31M1.91M2.75M1.38M1.39M1.88M1.36M1.34M1.25M2.80M0.92M2.17M0.42M
Net income details
EBT -4.65M-4.34M-2.40M-12.26M-8.82M-16.84M-5.54M-16.69M1.71M14.77M7.55M-23.18M-18.74M-24.96M-14.71M-18.11M-15.56M-16.95M-8.13M-20.59M-19.68M-21.15M-14.64M
Tax Provisions -0.07M0.01M-0.01M0.15M-0.86M-0.92M-0.67M-2.02M-0.52M-1.14M-0.60M-0.82M-0.04M-0.01M-0.00M0.00M-0.02M-0.03M-0.07M
Profit After Tax -3.95M-3.66M0.20M-10.53M-15.39M-15.98M-4.57M-15.17M2.60M15.69M8.24M-21.19M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Income from Non-Controlling Interests -0.13M-0.07M0.04M-0.07M-0.12M-0.06M-0.01M-0.06M-0.02M-0.00M-0.02M-0.09M-0.04M-0.02M-0.05M0.00M-0.03M-0.01M-0.01M-0.05M-0.01M0.01M-0.01M
Income from Continuing Operations -4.65M-4.34M-2.40M-12.26M-8.76M-16.86M-5.53M-16.84M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Consolidated Net Income -4.65M-4.34M-2.40M-12.26M-8.76M-16.86M-5.53M-16.84M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Income towards Parent Company -4.65M-4.34M-2.40M-12.26M-8.76M-16.86M-5.53M-16.84M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Net Income towards Common Stockholders -4.65M-4.34M-2.40M-12.26M-8.76M-16.86M-5.53M-16.84M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M
Additional items
EPS (Basic) -0.49-0.450.02-1.32-1.90-0.64-0.13-0.380.070.420.22-0.57-0.48-0.62-0.37-0.45-0.40-0.43-0.21-0.52-0.49-0.52-0.36
EPS (Weighted Average and Diluted) 0.01-1.32-1.90-0.64-0.13-0.380.070.410.22-0.55-0.48-0.62-0.37-0.45-0.40-0.43-0.21-0.52-0.49-0.52-0.36
Shares Outstanding (Weighted Average) 7.82M7.90M8.06M24.90M37.20M37.25M37.25M38.01M38.41M38.53M38.39M38.77M39.04M39.42M39.35M40.27M40.34M40.66M
Shares Outstanding (Diluted Average) 38.26M38.23M38.17M38.01M38.41M38.53M38.39M38.77M39.04M39.42M39.35M40.27M40.34M40.66M
EBITDA -4.65M-4.34M-1.43M-9.63M-6.17M-16.84M-5.54M-16.67M0.65M13.23M7.24M-25.09M-13.64M-18.22M-21.93M-9.50M-17.10M-16.78M1.07M-30.92M-15.01M-12.84M-17.50M
Interest Expenses 0.97M2.63M2.65M0.02M0.07M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M
Tax Rate 0.74%-0.07%0.13%-0.90%-50.44%-6.19%-8.93%8.71%2.75%4.55%4.10%4.53%0.24%0.04%0.04%-0.01%0.11%0.12%0.48%